Lupin Gets Long-Pending U.S. FDA Approval For Key Generic Asthma Drug
The Lupin Ltd. pharmaceutical plant stands in Salcette, Goa, India. (Photographer: Dhiraj Singh/Bloomberg)

Lupin Gets Long-Pending U.S. FDA Approval For Key Generic Asthma Drug

Lupin Ltd. has received the U.S. drug regulator’s approval to make the generic of a key asthma therapy at a time the threat of the new pneumonia-causing coronavirus looms over the world.The U. S. F...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.